FDA Inspection
Medtech Southeast, Inc.Medtech Southeast, Inc. – FDA Inspection, Apr 30, 2009
Record Details
This FDA Inspection record concerns Medtech Southeast, Inc., with an inspection on April 30, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Medtech Southeast, Inc.
- Inspection Date
- April 30, 2009
- Product Type
- Biologics
View Company Profile
ID · 1080216b-4e0c-4f72-9fc9-1fcd48293a58
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 588497
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Medtech Southeast, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 11, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 23, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 21, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 3, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Medtech Southeast, Inc.
- FDA Inspection 1067958 - 2018-07-11
- FDA Inspection 981296 - 2016-08-23
- FDA Inspection 887821 - 2014-07-21
- FDA Inspection 712252 - 2011-03-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.